Journal of Vascular Surgery
Volume 28, Issue 5 , Pages 909-918 , November 1998

Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model

Presented at the Twenty-second Annual Meeting of The Southern Association for Vascular Surgery, Rio Grande, Puerto Rico, Jan 21–24, 1998.

Received 28 January 1998 ,Accepted 22 June 1998.

References 

  1. North American Symptomatic Carotid Endarterectomy Trial Collaborators . Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453
  2. Healy DA, Zierler RE, Nicholls SC, Clowes AW, Primozich JF, Bergelin RO, et al.  Long-term follow-up and clinical outcome of carotid restenosis. J Vasc Surg. 1989;10:662–669
  3. Mattos MA, van Bemmelen PS, Barkmeier LD, Hodgson KJ, Ramsey DE, Sumner DS. Routine surveillance after carotid endarterectomy: does it affect clinical management?. J Vasc Surg. 1993;17:819–831
  4. Irvine C, Wilson YG, Currie IC, McGrath C, Scott J, Day A, et al.  Hyperhomocysteinemia is a risk factor for vein graft stenosis. Eur J Vasc Endovasc Surg. 1996;12:304–309
  5. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. Lab Invest. 1983;49:327–333
  6. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood. 1997;90:1–11
  7. Guba SC, Fink LM, Fonseca V. Hyperhomocycsteinemia—an emerging and important risk factor for thromboembolic and cardiovascular disease. Am J Clin Pathol. 1996;106:709–722
  8. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA. 1995;274:1049–1057
  9. Selhub J, Jacques PF, Bostom AG, et al.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286–291
  10. Malinow ME. Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review. Clin Chem. 1995;41:173–176
  11. Taylor LM, DeFrang RD, Harris EJ, Porter JM. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg. 1991;13:128–136
  12. Law MM, Gelabert HA, Moore WS, Hajjar GE, Colburn MD, Petrik PV, et al.  Cigarette smoking increases the development of intimal hyperplasia after vascular injury. J Vasc Surg. 1996;23:401–409
  13. Ubbink JB, Hayward Vermaak WJ, Bissbort S. Rapid highperformance liquid chromatography assay for total homocysteine levels in human serum. J Chromatogr A. 1991;565:441–446
  14. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;94:1655–1664
  15. Zalewski A, Shi Y. Vascular myofibroblasts: lessons from coronary repair and remodeling. Arterioscler Thromb Vasc Biol. 1997;17:417–422
  16. Nehler MR, Taylor LM, Porter JM. Homocysteinemia as a risk factor for atherosclerosis: a review. Cardiovasc Pathol. 1997;6:1–9
  17. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. Circulation. 1993;87:1107–1113
  18. Lee JS, Adrie C, Jacob HJ, Roberts JD, Zapol WM, Bloch KD. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res. 1996;78:337–342
  19. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in a rat carotid artery. Proc Natl Acad Sci U S A. 1989;86:8412–8416
  20. Spallone A, Sasaki T, Kassell NF. Time course of thrombotic changes after microsurgical carotid endarterectomy in the rat. Neurosurgery. 1985;16:773–779
  21. Rasmussen K, Moller J, Lyngbak M, Pedersen A-MH, Dybkjer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem. 1996;42:630–636
  22. Lin JY, Kang SS, Zhou J, Wong PWK. Homocysteinemia in rats induced by folic acid deficiency. Life Sci. 1989;44:319–325
  23. Taylor LM, Porter JM. Elevated plasma homocysteine as a risk factor for atherosclerosis. Semin Vasc Surg. 1993;6:36–45
  24. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schleèe R, et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A. 1994;91:6369–6373
  25. Lubec B, Labudova O, Hoeger H, Muehl A, Fang-Kircher S, Marx M, et al.  Homocysteine increases cyclin-dependent kinase in aortic rat tissue. Circulation. 1996;94:2620–2625
  26. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877–881
  27. Masser PA, Taylor LM, Porter JM. Importance of elevated plasma homocysteine levels as a risk factor for atherosclerosis. Ann Thorac Surg. 1994;58:1240–1246

 From the Division of Vascular Surgery, Department of Surgery, and the Department of Pathology (Dr Fink), University of Arkansas for Medical Sciences and Veterans Administration Hospital, and the Division of Molecular Epidemiology (Dr Cooney), National Center for Toxicological Research.

☆☆ Reprint requests: Mohammed M. Moursi, MD, Assistant Professor, Division of Vascular Surgery, VA Medical Center, Vascular Lab (112PV/LR), 4300 W 7th St, Little Rock, AR 72205.

 24/6/92619

PII: S0741-5214(98)70069-2

Journal of Vascular Surgery
Volume 28, Issue 5 , Pages 909-918 , November 1998